On (b)(6) 2021, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
It was reported that a patient underwent cardiac ablation procedure for atrial fibrillation (afib) with navistar® rmt thermocool® electrophysiology catheter and suffered cardiac tamponade requiring surgical intervention.It was reported that a single transseptal sheath was paced across.Device evaluation details: the device evaluation has been completed.The device was visually inspected and it was found in good conditions.The temperature and electrical features were tested and no issues were observed.In addition, the catheter was irrigating correctly.Then, magnetic sensor functionality was tested on carto and the catheter failed the test since the icon was observed in a reverse position.A failure analysis was performed, the catheter was dissected, and the sensor values were found within product specification, with this information, the failure related with reverse icon can be attributed to a potential pc board failure.A manufacturing record evaluation was performed and no internal actions related to the reported complaint were identified.The customer complaint cannot be confirmed.The root cause of the adverse event remains unknown.The instructions for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.The root cause of the reverse icon or pc board failure identified during product evaluation cannot be determined; potential cause traced to the component failure (circuit board/pc board).Additionally, during product evaluation/testing, the lot number was identified by electronically erasable programmable read only memory (eeprom) as 30410835m.As such, field d4.Lot number has been populated.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|